Psychedelic Stocks Soar After Trump Order; RBC Says Commercialization Path Could Accelerate

Psychedelic Stocks Soar After Trump Order; RBC Says Commercialization Path Could Accelerate Psychedelic drug stocks soared in premarket trading in New York after President Trump signed an executive order aimed at accelerating research and expanding access to therapies used for post-traumatic stress disorder (PTSD). "The executive order I'm signing, we're actually signing the executive order today, is really a moment," Trump said at the signing event. "These treatments are currently in the advanced stages of clinical trials to ensure that they're both safe and effective for the American patients." President Trump...